GEN Exclusives

More »

GEN News Highlights

Back to Item »

Sangamo Stock Nosedives on Decision to Discontinue Lead ZFP Candidate

Phase II study with diabetic neuropathy candidate SB-509 failed to meet primary and secondary endpoints.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Violent Video Games and Aggression

Do you think there is a link between violent video games and criminal violence?

More »